Since subtypes of breast cancer differ in their risk-factor associations and preventive strategies are often tailored to specific subtypes (e.g., based on estrogen receptor status), subtype-specific risk models could improve the identification of women most likely to benefit from targeted interventions. The gene discussed is ESR1; the disease is breast cancer.